Chemo-boosting drug discovered for leukaemia
Drugs developed to treat heart and blood vessel problems could be used to treat leukaemia...
List view / Grid view
Drugs developed to treat heart and blood vessel problems could be used to treat leukaemia...
Researchers have developed a radioactive ‘tracer’ molecule to detect myeloid-derived suppressor cells’ accumulating in the lung in preparation for the arrival of breast cancer cells...
Dr Reda Lebcir from the University of Hertfordshire is part of an international team of researchers awarded a £2m grant from the ESRC (Economic and Social research Council).
Research from King’s College in London, UK, and Lund University in Sweden could explain why diabetes drugs that have worked in animal experiments are not equally successful in humans. The researchers discovered differences – as well as hitherto unknown similarities – in the function of insulin-producing beta cells.
Since the sequence of the human genome was published some 20 years ago, omics strategies have enabled the generation of detailed molecular signatures of cancers and their subtypes.
Over 10 million units of platelets are transfused worldwide each year in one of the most common procedures in clinical medicine. However, platelets derived from human donors can transmit infections and trigger serious immune reactions that eventually render the therapy ineffective (a condition known as alloimmune refractoriness). In addition, since…
24 August 2016 | By Niamh Louise Marriott, Digital Content Producer
The stria vascularis is essential for normal hearing and is involved in maintaining the endocochlear potential - a difference in charged molecules between compartments of the inner ear which act like a battery to power the transmission of sound signals from the ear to the brain...
5 July 2016 | By Victoria White, Digital Content Producer
A new study has identified genetic mutations affecting the immune system which may lead to the development of more than one colorectal cancer tumour at the same time...
9 June 2016 | By Victoria White, Digital Content Producer
Drugs currently being trialled in cancer patients have been used to successfully target an autoimmune condition, uveitis, in mice...
23 March 2016 | By Dr John Maher, Principal Investigator, National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Guy’s and St Thomas’ and Kings College London
Here, Dr John Maher of the NIHR BRC at Guy's and St Thomas' and Kings College London discusses CAR T-cell therapy and the exciting frontier the technique has opened up in the battle against cancer...
20 October 2015 | By Victoria White
Researchers found that when HIFalpha was ‘switched off’, nerve function in flies with Parkinson’s disease was restored...
6 July 2015 | By Victoria White
A protein dubbed 'Bcl-Rambo' can protect against heart failure, suggests new research from King's College London and funded by the British Heart Foundation...
24 June 2015 | By Victoria White
Scientists have identified a single blood protein that may indicate the development a disorder associated with an increased risk of Alzheimer's disease...